Name | HSDVHK-NH2 |
---|
Description | HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM)[1][2]. |
---|---|
Related Catalog | |
Target |
αvβ3:2.74 nM (IC50) |
In Vitro | HSDVHK significantly inhibited bFGF-induced cell migration compared to the PBS control group[1]. The Arg-Gly-Asp (RGD)-binding site recognition by HSDVHK-NH2 (P11) is site specific because the HSDVHK-NH2 (P11) is inactive for the complex formation of a denatured form of integrin–vitronectin. HSDVHK-NH2 (P11) shows a strong antagonism against avb3-GRGDSP interaction with an IC50 value of 25.72 nM[2]. HSDVHK-NH2 (P11) inhibits the HUVEC proliferation due to the induction of HUVEC cell death through caspases activations and its mechanism is related with increased p53 expression[3]. Cell Proliferation Assay[3] Cell Line: HUVEC cells. Concentration: 0.1, 1, 10, and 100 μg/mL. Incubation Time: 72 h. Result: Significantly inhibited HUVEC proliferation on denatured collagen-coated plates in a dose-dependent manner. |
References |
Molecular Formula | C30H48N12O9 |
---|---|
Molecular Weight | 720.78 |